• Syndax Pharmaceuticals granted stock options covering up to 213,500 shares to five new employees on Nov. 4, 2026.
• The awards fall under the 2023 Inducement Plan and vest over four years, subject to continued service.
• Vesting begins with 25% on the first anniversary of the vesting commencement date, followed by 1/48th monthly over 36 months.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Syndax Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611041601PRIMZONEFULLFEED9869699) on November 04, 2026, and is solely responsible for the information contained therein.